Canada to allow import of J&J vaccine doses made at Emergent facility
![Canada to allow import of J&J vaccine doses made at Emergent facility](https://i-invdn-com.investing.com/trkd-images/LYNXMPEHAN0SW_L.jpg)
© Reuters. FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – The Canadian health regulator said on Wednesday it would allow Johnson & Johnson (NYSE:) to import its COVID-19 vaccine made at contract manufacturer Emergent BioSolutions Inc’s plant in Baltimore, Maryland.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Read More: Canada to allow import of J&J vaccine doses made at Emergent facility